ICP-923

N/A

Report date: 2025/02/06 13:34:34
NME

Base Information

Drug NameICP-923
Drug Alias NameICP-923
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 17A blockers
TargetsInterleukin 17A
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInnoCare Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnoCare Pharma Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A